Sürekli Renal Replasman Tedavisinin Ekstrarenal Endikasyonları
Özet
Referanslar
Bellomo R, Kellum JA, La Manna G, Ronco C (eds). 40 Years of Continuous Renal Replacement Therapy. Contrib Nephrol. Basel, Karger, 2018, vol 194, 90-98
Fleming GM, Walters S, Goldstein SL et al. Nonrenal indications for continuous renal replacement therapy: A report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry Group. Pediatric Critical Care Medicine 2012;13(5),299-304.
Joannidis M, Forni LG. Clinical review: timing of renal replacement therapy. Critical care 2011;15(3):223.
Ostermann M, Joannidis M, Pani A et al.17th Acute Disease Quality Initiative. Patient selection and timing of continuous renal replacement therapy. Blood purification 2016;42(3):224-37.
Costanzo MR, Saltzberg MT, Jessup M, Teerlink JR, Sobotka PA. Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. Journal of cardiac failure 2010;16.4:277-84.
Ricci Z, Ronco C, D’Amico G et al. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol Dial Transplant 2006;21:690-6.
Payen D, Mateo J, Cavaillon JM, Fraisse F, Floriot C, Vicaut E. Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Crit Care Med 2009;7:803-10
Joannes-Boyau O, Honore PM, Perez P et al. Highvolume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med 2013;39:1535-46.
Atan R, Peck L, Visvanathan K et al. High cut-off hemofiltration versus standard hemofiltration: effect on plasma cytokines. Int J Artif Organs 2016;39:479-86.
Mirrakhimov AE, Barbaryan A, Gray A, Ayach T. The role of renal replacement therapy in the management of pharmacologic poisonings. International journal of nephrology 2016;1-12.
Kanagasundaram NS, Lewington A. Dialytic therapies for drug overdose and poisoning. In: Richard JJ, Feehall J, Floege J; eds. Comprehensive Clinical Nephrology. 5th edition New york : Mosby Pr, 2014 98:1116-1121.
Kım JY, Lee Y, Cho H. Optimal prescriptions of continuous renal replacement therapy in neonates with hyperammonemia. Blood purification 2019;47.1-3:16-22.
Fehervari I, Fazakas J, Gerlei Z, Nemes B, Kobori L. Mitigation of cytokine storm by intraoperative use of renal replacement therapy during combined liver-kidney transplantation. In: Transplantation proceedings. Elsevier 2010; 2353-2356.
Forni LG, Hilton PJ. Continuous hemofiltration in the treatment of acute renal failure. N Engl J Med 1997;336:1303-9.
Schep LJ, Slaughter RJ, Temple WA, Beasley DM. Diethylene glycol poisoning. Clinical toxicology 2009;47.6:525-35.
Abramson S, Singh AK. Treatment of the alcohol intoxications: ethylene glycol, methanol and isopropanol. Curr Opin Nephrol Hypertens 2000;9:695-701.
Hovda KE, Froyshov S, Gudmundsdottir H, Rudberg N, Jacobsen D.Fomepizole may change indication for hemodialysis in methanol poisoning: prospective study in seven cases. Clin Nephrol 2005;64:190-7.
Juurlink DN, Gosselin S, Kielstein JT et al. Extracorporeal treatment of salicylate poisoning: systematic review and recommendations from the EXTRIP workgroup. Ann Emerg Med 2015; 66(2):165-81.
Ward ME, Musa MN, Bailey L. Clinical pharmacokinetics of lithium. Journal of Clinical Pharmacology 1994; 34:280-5.
Okusa MD, Crystal LJ. Clinical manifestations and management of acute lithium intoxication. Am J Med 1994;97:383-9.
Sood MM, Richardson R. Negative anion gap and elevated osmolar gap due to lithium overdose. Canadian Medical Association Journal 200; 176:7 921-3.
Beckmann U, Oakley PW, Dawson AH, Byth PL. Efficacy of continuous venovenous hemodialysis in the treatment of severe lithium toxicity. J Toxicol Clin Toxicol 2001;39:393-7.
Ghannoum M, Laliberte M, Nolin TD et al. Extracorporeal treatment for valproic acid poisoning: systematic review and recommendations from the EXTRIP workgroup,” Clinical Toxicology 2015; 53.5: 454-65.
Van Keulen JG, Van Wijk JA, Touw DJ, Van der Deure J, Markhorst DG, Gemke RJ. Effectiveness of haemofiltration in valproic acid intoxication. Acta Paediatr 2001;90: 958-9.
Scheen AJ. Clinical pharmacokinetics of metformin. Clin Pharmacokinet 1996;30: 359-71.
Rifkin SI, McFarren C, Juvvadi R, Weinstein SS. Prolonged hemodialysis for severe metformin intoxication. Renal Failure 2011:33:4 459-61.
Barrueto F, Meggs WJ, Barchman MJ: Clearance of metformin by hemofiltration in overdose. J Toxicol Clin Toxicol 2002;40:177-80.
Bouchard J, Ghannoum, M, Bernier-Jean A et al. Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran. Clinical Toxicology 2015; 53(3):156-63.
Pilapil M, Petersen J. Efficacy of hemodialysis and charcoal hemoperfusion in carbamazepine overdose. Clin Toxicol (Phila) 2008;46:342-3.
Askenazi DJ, Goldstein SL, Chang IF, Elenberg E, Feig DI. Management of a severe carbamazepine overdose using al bumin-enhanced continuous venovenous hemodialysis. Pediatrics 2004;113:406-9.
Agostini M, Bianchin A. Acute renal failure from organophosphate poisoning: a case of success with haemofiltration. Hum Exp Toxicol 2003;22:165-7.
Goebel J, Ananth M, Lewy JE. Hemodiafiltration for vancomycin overdose in a neonate with end-stage renal failure. Pediatr Nephrol 1999;13:423-5.
Jambou P, Levraut J, Favier C, Ichai C, Milano G, Grimaud D. Removal of methotrexate by continuous venovenous hemodiafiltration. Contrib Nephrol 1995;116:48-52.
Kanakiriya S, De Chazal I, Nath KA, Haugen EN, Albright RC, Juncos LA. Iodine toxicity treated with hemodialysis and continuous venovenous hemodiafiltration. Am J Kidney Dis 2003;41:702-8.
Domoto DT, Brown WW, Bruggensmith P. Removal of toxic levels of N-acetylprocainamide with continuous arteriovenous hemofiltration or continuous arteriovenous hemodiafiltration. Ann Intern Med 1987;106:550-2.
Böhler J, Riegel W, Keller E, Logemann E, Just H, Schollmeyer PJ. Continuous arteriovenous haemoperfusion (CAVHP) for treatment of paraquat poisoning. Nephrol Dial Transplant 1992;7:875-87
Referanslar
Bellomo R, Kellum JA, La Manna G, Ronco C (eds). 40 Years of Continuous Renal Replacement Therapy. Contrib Nephrol. Basel, Karger, 2018, vol 194, 90-98
Fleming GM, Walters S, Goldstein SL et al. Nonrenal indications for continuous renal replacement therapy: A report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry Group. Pediatric Critical Care Medicine 2012;13(5),299-304.
Joannidis M, Forni LG. Clinical review: timing of renal replacement therapy. Critical care 2011;15(3):223.
Ostermann M, Joannidis M, Pani A et al.17th Acute Disease Quality Initiative. Patient selection and timing of continuous renal replacement therapy. Blood purification 2016;42(3):224-37.
Costanzo MR, Saltzberg MT, Jessup M, Teerlink JR, Sobotka PA. Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. Journal of cardiac failure 2010;16.4:277-84.
Ricci Z, Ronco C, D’Amico G et al. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol Dial Transplant 2006;21:690-6.
Payen D, Mateo J, Cavaillon JM, Fraisse F, Floriot C, Vicaut E. Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Crit Care Med 2009;7:803-10
Joannes-Boyau O, Honore PM, Perez P et al. Highvolume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med 2013;39:1535-46.
Atan R, Peck L, Visvanathan K et al. High cut-off hemofiltration versus standard hemofiltration: effect on plasma cytokines. Int J Artif Organs 2016;39:479-86.
Mirrakhimov AE, Barbaryan A, Gray A, Ayach T. The role of renal replacement therapy in the management of pharmacologic poisonings. International journal of nephrology 2016;1-12.
Kanagasundaram NS, Lewington A. Dialytic therapies for drug overdose and poisoning. In: Richard JJ, Feehall J, Floege J; eds. Comprehensive Clinical Nephrology. 5th edition New york : Mosby Pr, 2014 98:1116-1121.
Kım JY, Lee Y, Cho H. Optimal prescriptions of continuous renal replacement therapy in neonates with hyperammonemia. Blood purification 2019;47.1-3:16-22.
Fehervari I, Fazakas J, Gerlei Z, Nemes B, Kobori L. Mitigation of cytokine storm by intraoperative use of renal replacement therapy during combined liver-kidney transplantation. In: Transplantation proceedings. Elsevier 2010; 2353-2356.
Forni LG, Hilton PJ. Continuous hemofiltration in the treatment of acute renal failure. N Engl J Med 1997;336:1303-9.
Schep LJ, Slaughter RJ, Temple WA, Beasley DM. Diethylene glycol poisoning. Clinical toxicology 2009;47.6:525-35.
Abramson S, Singh AK. Treatment of the alcohol intoxications: ethylene glycol, methanol and isopropanol. Curr Opin Nephrol Hypertens 2000;9:695-701.
Hovda KE, Froyshov S, Gudmundsdottir H, Rudberg N, Jacobsen D.Fomepizole may change indication for hemodialysis in methanol poisoning: prospective study in seven cases. Clin Nephrol 2005;64:190-7.
Juurlink DN, Gosselin S, Kielstein JT et al. Extracorporeal treatment of salicylate poisoning: systematic review and recommendations from the EXTRIP workgroup. Ann Emerg Med 2015; 66(2):165-81.
Ward ME, Musa MN, Bailey L. Clinical pharmacokinetics of lithium. Journal of Clinical Pharmacology 1994; 34:280-5.
Okusa MD, Crystal LJ. Clinical manifestations and management of acute lithium intoxication. Am J Med 1994;97:383-9.
Sood MM, Richardson R. Negative anion gap and elevated osmolar gap due to lithium overdose. Canadian Medical Association Journal 200; 176:7 921-3.
Beckmann U, Oakley PW, Dawson AH, Byth PL. Efficacy of continuous venovenous hemodialysis in the treatment of severe lithium toxicity. J Toxicol Clin Toxicol 2001;39:393-7.
Ghannoum M, Laliberte M, Nolin TD et al. Extracorporeal treatment for valproic acid poisoning: systematic review and recommendations from the EXTRIP workgroup,” Clinical Toxicology 2015; 53.5: 454-65.
Van Keulen JG, Van Wijk JA, Touw DJ, Van der Deure J, Markhorst DG, Gemke RJ. Effectiveness of haemofiltration in valproic acid intoxication. Acta Paediatr 2001;90: 958-9.
Scheen AJ. Clinical pharmacokinetics of metformin. Clin Pharmacokinet 1996;30: 359-71.
Rifkin SI, McFarren C, Juvvadi R, Weinstein SS. Prolonged hemodialysis for severe metformin intoxication. Renal Failure 2011:33:4 459-61.
Barrueto F, Meggs WJ, Barchman MJ: Clearance of metformin by hemofiltration in overdose. J Toxicol Clin Toxicol 2002;40:177-80.
Bouchard J, Ghannoum, M, Bernier-Jean A et al. Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran. Clinical Toxicology 2015; 53(3):156-63.
Pilapil M, Petersen J. Efficacy of hemodialysis and charcoal hemoperfusion in carbamazepine overdose. Clin Toxicol (Phila) 2008;46:342-3.
Askenazi DJ, Goldstein SL, Chang IF, Elenberg E, Feig DI. Management of a severe carbamazepine overdose using al bumin-enhanced continuous venovenous hemodialysis. Pediatrics 2004;113:406-9.
Agostini M, Bianchin A. Acute renal failure from organophosphate poisoning: a case of success with haemofiltration. Hum Exp Toxicol 2003;22:165-7.
Goebel J, Ananth M, Lewy JE. Hemodiafiltration for vancomycin overdose in a neonate with end-stage renal failure. Pediatr Nephrol 1999;13:423-5.
Jambou P, Levraut J, Favier C, Ichai C, Milano G, Grimaud D. Removal of methotrexate by continuous venovenous hemodiafiltration. Contrib Nephrol 1995;116:48-52.
Kanakiriya S, De Chazal I, Nath KA, Haugen EN, Albright RC, Juncos LA. Iodine toxicity treated with hemodialysis and continuous venovenous hemodiafiltration. Am J Kidney Dis 2003;41:702-8.
Domoto DT, Brown WW, Bruggensmith P. Removal of toxic levels of N-acetylprocainamide with continuous arteriovenous hemofiltration or continuous arteriovenous hemodiafiltration. Ann Intern Med 1987;106:550-2.
Böhler J, Riegel W, Keller E, Logemann E, Just H, Schollmeyer PJ. Continuous arteriovenous haemoperfusion (CAVHP) for treatment of paraquat poisoning. Nephrol Dial Transplant 1992;7:875-87
